Research News and Research

RSS

Anticoagulant Pradaxa receives FDA approval for prevention of stroke in atrial fibrillation patients

The U.S. Food and Drug Administration today approved Pradaxa capsules (dabigatran etexilate) for the prevention of stroke and blood clots in patients with abnormal heart rhythm (atrial fibrillation).

20 Oct 2010

Autistic children with poor diet face risk of vision loss due to vitamin B12 deficiency

Autistic children with severely limited diets may be at risk for vision loss due to vitamin B12 deficiency, according to new research from The Children's Hospital of Philadelphia. Doctors should consider this deficiency when evaluating and treating children with autism and vision loss, the authors said.

20 Oct 2010

Opinions: Mdgs in Africa; development maintenance; U.S. efforts to eradicate polio; Global Fund commitment

Addressing the Millennium Development Goals (MDGs) in Africa will not only require extra spending, but also better spending, as well as the improvement of social services and priority setting, Kingsley Alu writes in a Leadership column.

20 Oct 2010

Genes and alcoholism link explored: Study

According to the latest research in the U.S., a genetic variation may protect against alcoholism, and this could lead to a novel preventative treatment. The researchers say that a gene variant known as CYP2EI is linked to people's response to alcohol.

19 Oct 2010

Fish oil not as good for pregnant mums as thought: Study

According to a new Australian study, taking fish oil / docosahexaenoic acid (DHA) supplements during pregnancy does not appear to reduce the risk of postpartum depression of mothers or boost the language development and cognitive skills of their children.

19 Oct 2010

Protein hormone inhibits leptin-induced migration of liver cancer cells

A research team from Emory University School of Medicine investigated the role between adiponectin and leptin in obesity-related carcinogenesis. Their findings, published in the November issue of Hepatology, suggest that the protein hormone adiponectin has potential for inhibiting the oncogenic actions of leptin, namely in hepatocellular carcinoma (HCC), and could offer a promising therapy for the disease.

19 Oct 2010

BioMarin announces BMN-111 program for treatment of achondroplasia

BioMarin Pharmaceutical Inc. today announced its program for BMN-111, a peptide therapeutic for the treatment of achondroplasia. BioMarin plans to file an IND in the fourth quarter of 2011 and to initiate a Phase 1 clinical trial by the first quarter of 2012.

19 Oct 2010

Forest Laboratories second quarter net sales increase 7.7% to $1,037.3 million

Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that diluted earnings per share equaled $1.00 in the second quarter of fiscal 2011.

19 Oct 2010

Scientists probe functional connectivity among neurons in auditory cortex gives rise to map of acoustic space

Just as we visually map a room by spatially identifying the objects in it, we map our aural world based on the frequencies of sounds. The neurons within the brain's "hearing center"-the auditory cortex-are organized into modules that each respond to sounds within a specific frequency band. But how responses actually emanate from this complex network of neurons is still a mystery.

19 Oct 2010

Pharmacy graduate awarded national recognition for pioneering research in genetics

A young pharmacy graduate has been awarded national recognition for her pioneering research in the field of genetics which has the potential to treat diseases such as cancer and Parkinson's.

19 Oct 2010

SheKnows City Guide helps women to get expert advice on health

SheKnows one of the fastest growing online content and community global destinations for women, just launched a new city-specific resource titled SheKnows City Guide.

19 Oct 2010

Celebrity health messages play an important role in society: Study

Celebrity journalism is often considered to be without merit, discounted due to its sensational details and lack of news value. MU researchers now say that celebrity journalism may be an underappreciated way to communicate health messages. In a recent award-winning paper, Amanda Hinnant, assistant professor of magazine journalism in the University of Missouri School of Journalism, found some readers of celebrity health stories report that the stories have an impact on their own behavior and how they discuss health issues.

19 Oct 2010

Research calls for better environmental risk assessments of pharmaceuticals

The strategies used to assess the environmental risks posed by pharmaceuticals are not enough to protect natural microbial communities, reveals a researcher from the University of Gothenburg (Sweden) who is calling for better environmental risk assessments.

19 Oct 2010

ProBuild raises $275,000 for City of Hope

ProBuild Company LLC, one of the nation's largest suppliers of building materials to professional contractors, continued its commitment to further cancer and diabetes research by hosting its 2010 Charity Golf Tournament at The Omni Interlocken Resort and Hotel in Broomfield, Colo. ProBuild and its supply partners from across the Rocky Mountain Region together raised more than $275,000 for City of Hope, one of the nation's leading research and treatment centers for cancer, diabetes and other life-threatening diseases.

19 Oct 2010

U.S. patient monitoring market to reach $4 billion by 2017: iData Research

According to a new report by iData Research the leading global authority in medical device and pharmaceutical market research, the U.S. patient monitoring market is expected to reach almost $4 billion by 2017.

19 Oct 2010

Syneron launches VelaBABE device for women to reclaim pre-baby body

Syneron Medical Ltd., a leading medical aesthetic device innovator, is announcing their new VelaBABE promotion for women who want to reclaim their pre-baby body with help from VelaShape.

19 Oct 2010

Novartis to implement Veeva CRM for global deployments

Veeva Systems announced today that Novartis Pharmaceuticals AG, a world leader in the research, development, manufacturing and marketing of products to protect and improve health and well-being, has chosen Veeva CRM® for various global deployments.

19 Oct 2010

Accium announces new pricing for AMS measurement service

Accium BioSciences, a leading provider of bioanalytical accelerator mass spectrometry (AMS) services in North America, announced today new pricing for its AMS measurement service at $99 per sample. GLP-compliant service is now available at $115 per sample. The new pricing includes sample graphitization and AMS measurement services.

19 Oct 2010

Adolor initiates ADL5945 Phase 2 proof-of-concept study for patients with OIC

Adolor Corporation today announced the initiation of a Phase 2 proof-of-concept (PoC) study of ADL5945 in patients suffering from opioid-induced constipation (OIC).

19 Oct 2010

Johnson & Johnson third quarter sales decrease 0.7% to $15.0 billion

Johnson & Johnson today announced sales of $15.0 billion for the third quarter of 2010, a decrease of 0.7% as compared to the third quarter of 2009. Operational results increased 0.1% and the negative impact of currency was 0.8%. Domestic sales declined 2.5%, while international sales increased 1.1%, reflecting operational growth of 2.6% and a negative currency impact of 1.5%.

19 Oct 2010